| abstract |
Angiogenesis-related diseases such as angiogenesis-dependent cancer, benign tumors, rheumatoid arthritis, psoriasis, ocular neovascular diseases, Osler-Weber syndrome, myocardial neovascularization, plaque neovascularization, telangiectasia, hemophilia Provision of a method for treating or preventing pathological joints, hemangiofibroma, wound granulation, intestinal adhesions, atherosclerosis, scleroderma, hypertrophic scar, cat scratch disease, Helicobacter pylori ulcer, and the like. Bone marrow-derived stem cells, mesenchymal progenitor cells (MPC) such as TNAP +, STRO-1 +, VCAM-1 +, THY-1 +, STRO-2 +, CD45 +, CD146 +, 3G5 + or any combination thereof And / or administration of their progeny cells. [Selection figure] None |